NCT04395053 - A Bioavailability Study of SHR1459 on Healthy Chinese Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 28, 2020

Primary Completion Date

July 11, 2020

Study Completion Date

August 1, 2020

Conditions

Healthy Adult Subjects

Interventions

DRUG

SHR1459

"TR group:~The first period，the subjects will be administrated with SHR-1459 in new formulation, then conduct blood collection within 48h; 7 days washout； The second period，the subjects will be administrated with SHR-1459 in old formulation, then conduct blood collection within 48h.~RT group:~The first period，the subjects will be administrated with SHR-1459 in old formulation, then conduct blood collection within 48h; 7 days washout； The second period，the subjects will be administrated with SHR-1459 in new formulation, then conduct blood collection within 48h."

Trial Locations (1)

410013

The Third Xiangya Hospital of Central South University, Changsha

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY